Trial Profile
An Open-Label Study to Assess the Safety and Efficacy of a Clinical Course of Oral Apabetalone in Hospitalized Subjects with 2019-nCoV Infection on Top of Standard of Care Compared to Standard of Care Alone
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 08 Jun 2020
Price :
$35
*
At a glance
- Drugs Apabetalone (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Resverlogix Corporation
- 08 Jun 2020 New trial record